On October 7, 2020, the Litigation and Biotechnology Committees presented a lively webinar panel discussion on current trends in biotechnology patent litigation. The topics included patentability, claim construction, and special issues in biotechnology patent litigation. The speakers were Claire Laporte (Head of Intellectual Property at Ginkgo Bioworks), Chelsea Loughran (shareholder at Wolf Greenfield), and Jake Holdreith (partner at Robins Kaplan LLP). The panel was moderated by litigation committee co-chair David Marder (partner at Robins Kaplan LLP).